On February 6, 2020 Immunis.AI, a privately held immunogenomics company with a patented liquid biopsy platform, reported that its President and Chief Executive Officer, Mark McDonough, will present at the BIO CEO & Investor Conference being held in New York City from February 10-11, 2020 (Press release, ImmunisAI, FEB 6, 2020, View Source [SID1234553955]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Date: Tuesday, February 11th

Time: 10:00 AM

Track: Diagnostics

Venue: Ziegfeld Room, New York Marriott Marquis, 1535 Broadway, New York, NY 10036

To schedule a meeting with Mark McDonough during the conference, please contact [email protected].